, Geneva: World Health Organization, 2016.

K. Dheda, T. Gumbo, and N. R. Gandhi, Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis, Lancet Respir Med, vol.2, issue.4, pp.321-338, 2014.
DOI : 10.1016/s2213-2600(14)70031-1

URL : http://europepmc.org/articles/pmc5526327?pdf=render

B. Lehner, Molecular mechanisms of epistasis within and between genes, Trends Genet, vol.27, issue.8, pp.323-331, 2011.
DOI : 10.1016/j.tig.2011.05.007

M. S. Breen, C. Kemena, P. K. Vlasov, C. Notredame, and F. A. Kondrashov, Epistasis as the primary factor in molecular evolution, Nature, vol.490, issue.7421, pp.535-538, 2012.
DOI : 10.1038/nature11510

S. Trindade, A. Sousa, K. B. Xavier, F. Dionisio, M. G. Ferreira et al., Positive epistasis drives the acquisition of multidrug resistance, PLoS Genet, vol.5, issue.7, p.1000578, 2009.

B. Müller, S. Borrell, G. Rose, and S. Gagneux, The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis, Trends Genet, vol.29, issue.3, pp.160-169, 2013.

S. Borrell, Y. Teo, and F. Giardina, Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis, Evol Med Public Health, vol.2013, issue.1, pp.65-74, 2013.

T. T. Committee, Streptomycin treatment of pulmonary tuberculosis: a medical research council investigation, Br Med J, vol.2, issue.4582, pp.769-782, 1948.

B. Pourakbari, S. Mamishi, M. Mohammadzadeh, and S. Mahmoudi, First-line anti-tubercular drug resistance of Mycobacterium tuberculosis in Iran: a systematic review, Front Microbiol, vol.7, p.1139, 2016.

J. A. Caminero, G. Sotgiu, A. Zumla, and G. B. Migliori, Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis, Lancet Infect Dis, vol.10, issue.9, pp.621-629, 2010.
DOI : 10.1016/s1473-3099(10)70139-0

M. Mir, S. Prisic, and C. M. Kang, Mycobacterial gene cuvA is required for optimal nutrient utilization and virulence, Infect Immun, vol.82, issue.10, pp.4104-4117, 2014.
DOI : 10.1128/iai.02207-14

URL : https://iai.asm.org/content/82/10/4104.full.pdf

A. K. Singh, X. Carette, and L. P. Potluri, Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system, Nucleic Acids Res, vol.44, issue.18, p.143, 2016.
DOI : 10.1093/nar/gkw625

URL : https://academic.oup.com/nar/article-pdf/44/18/e143/16663088/gkw625.pdf

J. H. Guo, W. L. Xiang, and Q. R. Zhao, Molecular characterization of drugresistant Mycobacterium tuberculosis isolates from Sichuan Province in China, Jpn J Infect Dis, vol.61, issue.4, pp.264-268, 2008.

F. Zeng, Y. Chen, and J. Remis, Structural basis of co-translational quality control by ArfA and RF2 bound to ribosome, Nature, vol.541, issue.7638, pp.554-557, 2017.
DOI : 10.2210/pdb5u4i/pdb

J. Piton, S. Petrella, and M. Delarue, Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase, PLoS One, vol.5, issue.8, p.12245, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-01126607

C. B. Ford, R. R. Shah, and M. K. Maeda, Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis, Nat Genet, vol.45, issue.7, pp.784-790, 2013.

C. Jenkins, J. Bacon, and J. Allnutt, Enhanced heterogeneity of rpoB in Mycobacterium tuberculosis found at low pH, J Antimicrob Chemother, vol.63, issue.6, pp.1118-1120, 2009.

M. A. Kohanski, M. A. Depristo, and J. J. Collins, Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis, Mol Cell, vol.37, issue.3, pp.311-320, 2010.
DOI : 10.1016/j.molcel.2010.01.003

URL : https://doi.org/10.1016/j.molcel.2010.01.003

S. Borrell and S. Gagneux, Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis, Clin Microbiol Infect, vol.17, issue.6, pp.815-820, 2011.

T. M. Walker, T. A. Kohl, and S. V. Omar, Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study, Lancet Infect Dis, vol.15, issue.10, pp.1193-1202, 2015.

G. Pelchovich, A. Zhuravlev, and U. Gophna, Effect of ribosome-targeting antibiotics on streptomycin-resistant Mycobacterium mutants in the rpsL gene, Int J Antimicrob Agents, vol.42, issue.2, pp.129-132, 2013.

B. Javid, F. Sorrentino, and M. Toosky, Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance, Proc Natl Acad Sci U S A, vol.111, issue.3, pp.1132-1137, 2014.
DOI : 10.1073/pnas.1317580111

URL : http://www.pnas.org/content/111/3/1132.full.pdf

D. I. Andersson, Persistence of antibiotic resistant bacteria, Curr Opin Microbiol, vol.6, issue.5, pp.452-456, 2003.
DOI : 10.1016/j.mib.2003.09.001

J. H. Lee, N. C. Ammerman, and S. Nolan, Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis, Nat Commun, vol.3, issue.2, p.753, 2012.

F. S. Spies, A. Von-groll, and A. W. Ribeiro, Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes, Tuberculosis, vol.93, issue.2, pp.150-154, 2013.

S. Baker, P. T. Duy, and T. V. Nga, Fitness benefits in fluoroquinoloneresistant Salmonella Typhi in the absence of antimicrobial pressure, Elife, vol.2, issue.49, p.1229, 2013.

D. Shcherbakov, R. Akbergenov, T. Matt, P. Sander, D. I. Andersson et al., Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis, Mol Microbiol, vol.77, issue.4, pp.830-840, 2010.

T. Vogwill, M. Kojadinovic, and R. C. Maclean, Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas, Proc Biol Sci, vol.283, p.20160151, 1830.
URL : https://hal.archives-ouvertes.fr/hal-01444160

P. Durão, S. Trindade, A. Sousa, and I. Gordo, Multiple resistance at no cost: rifampicin and streptomycin a dangerous liaison in the spread of antibiotic resistance, Mol Biol Evol, vol.32, issue.10, pp.2675-2680, 2015.

H. Stower, Molecular evolution: epistasis prevails, Nat Rev Genet, vol.13, issue.12, p.828, 2012.
DOI : 10.1038/nrg3369

P. P. Salvatore, M. C. Becerra, A. Zur-wiesch, and P. , Fitness costs of drug resistance mutations in multidrug-resistant Mycobacterium tuberculosis: a household-based case-control study, J Infect Dis, vol.213, issue.1, pp.149-155, 2016.

, Infection and Drug Resistance, vol.17, issue.07, 2018.